Manuel Moreno casteo

Manuel Moreno casteo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2021 in Molecules
Verified
Journal Article
Open access
PDF file
LVLucía Viejo
Lucía Viejo
MRMarcos Rubio-Alarcón
Marcos Rubio-Alarcón
RARaquel L. Arribas
Raquel L. Arribas
MCManuel Moreno casteo
Manuel Moreno casteo
RPRaquel Pérez-Marín
Raquel Pérez-Marín
Cristobal De Los RiosCristobal De Los Rios
Cristobal De Los Rios
In excitable cells, mitochondria play a key role in the regulation of the cytosolic Ca2+ levels. A dysregulation of the mitochondrial Ca2+ buffering machinery derives in serious pathologies, where neurodegenerative diseases highlight. Since the mitochondrial Na+/Ca2+ exchanger (NCLX) is the principal efflux pathway of Ca2+ to the cytosol, drugs capable of blocking NCLX have been proposed to act as neuroprotectants in neuronal damage scenarios exacerbated by Ca2+ overload. In our search of optimized NCLX blockers with augmented drug-likeness, we herein describe the synthesis and pharmacological characterization of new benzothiazepines analogues to the first-in-class NCLX blocker CGP37157 and its further derivative ITH12575, synthesized by our research group. As a result, we found two new compounds with an increased neuroprotective activity, neuronal Ca2+ regulatory activity and improved drug-likeness and pharmacokinetic properties, such as clog p or brain permeability, measured by PAMPA experiments.